Long-Term Infant Outcomes After In Utero Biologic Exposure: Results From the Pregnancy Inflammatory Disease Neonatal
Arushi Kohli1, Millie D Long2, Dawn B Beaulieu3
1Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, California, USA.
Introduction:
Long-term data are needed for offspring exposed in utero to medications for inflammatory bowel disease (IBD).
Methods:
We used a prospective cohort of pregnant women with IBD and their offspring (Pregnancy in IBD and Neonatal Outcomes) to compare rates of serious infection, congenital malformations, and developmental delay by medication exposures.
Results:
We included 438 offspring with at least 4 years of follow-up. No differences in adverse outcomes were observed by medication. Preterm birth, but not specific drug exposure, was associated with infection risk. Breastfeeding was not associated with serious infection differences.
Discussion:
These findings support the use of effective IBD therapies throughout pregnancy.
More Related Videos
Related Concept Videos
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:07Teratogenicity